Heterogeneity in genomic risk assessment from tissue based prognostic signatures used in the biopsy setting and the impact of MRI targeted biopsy
Journal of Urology, December 2020
Ductal prostate cancers semonstrate poor outcomes with conventional therapies
European Urology, December 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) improves metastasis-free survival compared to neoadjuvant ADT: An individual patient meta-analysis
Journal of Clinical Oncology, December 2020
MRI characteristics accurately predict biochemical recurrence after radical prostatectomy
Journal of Clinical Medicine, November 2020
Advanced prostate cancer with ATM loss: PARP and ATR inhibitors
European Urology, November 2020
Patient-reported financial toxicity associated with contemporary treatment for localized prostate cancer
Journal of Urology, November 2020
Selecting patients with favourable-risk, GG2 prostate cancer for active surveillance: Does MRI have a role?
Journal of Urology, November 2020
The use of healthcare services by prostate cancer patients in the last 12 months of life: How do we improve the quality of care during this period?
Journal of Palliative Care, November 2020
A DROP-IN gamma probe for robot-assisted radioguided surgery of lymph nodes during radical prostatectomy
European Urology, November 2020
Risk of cardiovascular disease following gonadotropinâreleasing hormone agonists vs antagonists in prostate cancer: Realâworld evidence from five databases
International Journal of Cancer, November 2020
The long-term risks of metastases in men on active surveillance for early stage prostate cancer
The Journal of Urology, December 2020
Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging
The journal of Nuclear Medicine, November 2020
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy. I agree Read More